TEUM Pareteum Corp. gains 19% Mar 28, 2018

N/A http://www.priceseries.com/trade/TEUM-Pareteum-Corp-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2018030220180328.html

SRI Stoneridge, Inc. gains 16% Mar 28, 2018

Stoneridge, Inc. designs and manufactures engineered electrical and electronic components, modules, and systems for the automotive, commercial, motorcycle, off-highway, and agricultural vehicle markets in North America, South America, Europe, and internationally. It operates through three segments: Control Devices, Electronics, and PST. The Control Devices segment provides sensors, switches, valves, and actuators, as well as other electronic products that monitors, measures, or activates specific functions within a vehicle; and actuator products that enable original equipment manufacturers (OEM) to deploy power functions in a vehicle, as well as to integrate switching and control functions. The Electronics segment offers electronic instrument clusters, electronic control units, and driver information systems. Its products collect, store, and display vehicle information, such as speed, pressure, maintenance data, trip information, operator performance, temperature, distance traveled, and driver messages related to vehicle performance. This segment's power distribution modules and systems regulate, coordinate, and direct the operation of the electrical system within a vehicle. The PST segment offers in-vehicle audio and video devices, electronic vehicle security alarms, convenience accessories, infotainment systems, and vehicle tracking devices and monitoring services. It offers its products and systems to various OEM and tier one supplier customers, as well as aftermarket distributors and mass merchandisers for use in various vehicle platforms. Stoneridge, Inc. was founded in 1965 and is headquartered in Novi, Michigan. http://www.priceseries.com/trade/SRI-Stoneridge-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2018030220180328.html

SNDX Syndax Pharmaceuticals, Inc. gains 36% Mar 28, 2018

Developing a therapy that enhances checkpoint immuno-oncology drugs. http://www.priceseries.com/trade/SNDX-Syndax-Pharmaceuticals-Inc-stock-gains-36-percent-a-Trade-Record-by-priceSeries-2018031220180328.html

OSG Overseas Shipholding Group, Inc. gains 27% Mar 28, 2018

Overseas Shipholding Group, Inc. primarily engages in the ocean transportation of crude oil and petroleum products. As of December 31, 2015, the company owned or operated a fleet of 79 vessels aggregating 7.4 million deadweight tons and 864,800 cu... http://www.priceseries.com/trade/OSG-Overseas-Shipholding-Group-Inc-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2018030820180328.html

OCLR Oclaro, Inc. gains 43% Mar 28, 2018

Oclaro, Inc. designs, manufactures, and markets lasers and optical components, modules, and subsystems for the optical communications, industrial, and consumer laser markets worldwide. The company's products generate, detect, combine, and separate light signals in optical communications networks. It offers client side transceivers, including pluggable transceivers; line side transceivers; tunable laser transmitters, such as discrete lasers and co-packaged laser modulators; lithium niobate modulators to manipulate the phase or the amplitude of an optical signal; transponder modules for transmitter and receiver functions; and discrete lasers and receivers for metro and long-haul applications. The company markets its products through direct sales force, as well as through sales representatives and resellers. It serves network equipment manufacturers of telecommunications and datacom systems, and hyperscale data center operators. The company was formerly known as Bookham, Inc. and changed its name to Oclaro, Inc. in April 2009. Oclaro, Inc. was founded in 1988 and is headquartered in San Jose, California. http://www.priceseries.com/trade/OCLR-Oclaro-Inc-stock-gains-43-percent-a-Trade-Record-by-priceSeries-2018021320180328.html

NIHD NII Holdings, Inc. gains 83% Mar 28, 2018

NII Holdings, Inc. provides wireless communication services under the Nextel brand in Brazil. It offers mobile telephone voice services; wireless data services, including text messaging, mobile Internet, and email services; and push-to-talk services, such as Direct Connect, and Prip and International Direct Connect services, which allow subscribers to talk to each other instantly. The company also provides other value-added services comprising location-based services, which include the use of global positioning system technologies; digital media services; and a range of applications available via its content management system, as well as the Android open application market. In addition, it offers business solutions consisting of security, work force management, logistics support, and other applications for its business subscribers to enhance their productivity; and voice and data roaming services. The company was formerly known as Nextel International, Inc. and changed its name to NII Holdings, Inc. in December 2001. NII Holdings, Inc. was founded in 1995 and is based in Reston, Virginia. http://www.priceseries.com/trade/NIHD-NII-Holdings-Inc-stock-gains-83-percent-a-Trade-Record-by-priceSeries-2018022320180328.html

GERN Geron Corporation gains 96% Mar 28, 2018

Geron Corporation operates as a biopharmaceutical company. The company supports the clinical stage development of a telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. It has collaboration and license agreement with Janssen Biotech, Inc. to develop and commercialize imetelstat worldwide for indications in oncology, including hematologic myeloid malignancies and other human therapeutic uses. The company was founded in 1990 and is based in Menlo Park, California. http://www.priceseries.com/trade/GERN-Geron-Corporation-stock-gains-96-percent-a-Trade-Record-by-priceSeries-2018022820180328.html

FLKS Flex Pharma, Inc. gains 36% Mar 28, 2018

Flex Pharma, Inc., a biotechnology company, develops and commercializes products for the treatment of muscle cramps and spasms associated with neurological conditions and exercise-associated muscle cramps in the United States. The company operates through two segments, Consumer Operations and Drug Development. Its lead drug candidate includes FLX-787, a single molecule, chemically synthesized, and transient receptor potential ion channel activator, which is in exploratory Phase 2 clinical trial in Australia for the treatment of patients with multiple sclerosis and amyotrophic lateral sclerosis. The company also offers HOTSHOT, a consumer beverage to prevent and treat exercise associated muscle cramps. It markets and sells its HOTSHOT product online through its e-commerce Website, as well as through third-party Websites. Flex Pharma, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts. http://www.priceseries.com/trade/FLKS-Flex-Pharma-Inc-stock-gains-36-percent-a-Trade-Record-by-priceSeries-2018030720180328.html

ENPH Enphase Energy, Inc. gains 63% Mar 28, 2018

Enphase Energy, Inc., together with its subsidiaries, designs, develops, and sells microinverter systems for residential and commercial markets in the United States and internationally. The company's semiconductor-based microinverter system converts direct current electricity to alternating current (AC) electricity at the individual solar module level. It also offers energy storage systems, including its AC battery; and energy monitoring and control services. The company sells its microinverter systems primarily to distributors, as well as directly to large installers through original equipment manufacturers and strategic partners. Enphase Energy, Inc. was founded in 2006 and is headquartered in Petaluma, California. http://www.priceseries.com/trade/ENPH-Enphase-Energy-Inc-stock-gains-63-percent-a-Trade-Record-by-priceSeries-2018022620180328.html

AXGN AxoGen, Inc. gains 44% Mar 28, 2018

AxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The company's surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida. http://www.priceseries.com/trade/AXGN-AxoGen-Inc-stock-gains-44-percent-a-Trade-Record-by-priceSeries-2018021320180328.html

ADAP Adaptimmune Therapeutics plc gains 24% Mar 28, 2018

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on the provision of cancer immunotherapy products based on its proprietary SPEAR T-cell platform. Its platform enables to identify cancer targets; find and genetically engineer T-cell receptors (TCR); and produce TCR therapeutic candidates for administration to patients. The company's lead program includes NY-ESO-1 and LAGE-1a cancer antigens, which are in Phase I/II clinical trials for patients with solid tumors, as well as hematological cancer types, including synovial sarcoma, multiple myeloma, non-small cell lung cancer (NSCLC), and ovarian cancer; and pilot trial for myxoid round cell liposarcoma. It is also developing MAGE A-10 peptide that is in Phase I/II clinical trials to treat urothelial (bladder), melanoma, and head and neck cancers, as well as NSCLC; AFP SPEAR T-cell therapeutic candidate that has completed preclinical testing for targeting a peptide associated with hepatocellular carcinoma; and MAGE-A4 to treat urothelial (bladder), melanoma, head and neck, esophageal and gastric, and ovarian cancer, as well as NSCLC. It has a strategic collaboration and licensing agreement with GlaxoSmithKline for the development and commercialization of the NY-ESO SPEAR T-cell program; and strategic alliance with MD Anderson Cancer Center for the development of T-cell therapies for various cancers. The company also has a clinical trial collaboration agreement with Merck & Co., Inc. for the assessment of NY-ESO SPEAR T-cell in combination with anti-programmed death-1 inhibitor in patients with multiple myeloma; and a research, collaboration, and license agreement with Universal Cells, Inc. to gene editing and HLA-engineering technology, as well as a collaboration agreement with Bellicum Pharmaceutical Inc. to evaluate, develop, and commercialize next generation T-cell therapies. Adaptimmune Therapeutics plc was founded in 2014 and is headquartered in Abingdon, the United Kingdom. http://www.priceseries.com/trade/ADAP-Adaptimmune-Therapeutics-plc-stock-gains-24-percent-a-Trade-Record-by-priceSeries-2018030820180328.html

UPLD Upland Software, Inc. gains 28% Mar 27, 2018

Upland Software, Inc. provides cloud-based enterprise work management software in the United States and internationally. It offers a family of cloud-based enterprise work management software applications under the Upland brand for the information technology, process excellence, finance, professional services, and marketing functions in organizations. The company's software applications address enterprise work challenges in various categories, including program and portfolio management, project management and collaboration, workflow automation and enterprise content management, digital engagement management, professional services automation, and financial management. It sells its products through a direct sales organization, as well as through distributors and value-added resellers. The company was formerly known as Silverback Enterprise Group, Inc. and changed its name to Upland Software, Inc. in November 2013. The company was founded in 2010 and is headquartered in Austin, Texas. Upland Software, Inc. is a subsidiary of Silverback Enterprise Group Inc. http://www.priceseries.com/trade/UPLD-Upland-Software-Inc-stock-gains-28-percent-a-Trade-Record-by-priceSeries-2018022120180327.html

GTHX G1 Therapeutics, Inc. gains 62% Mar 27, 2018

N/A http://www.priceseries.com/trade/GTHX-G1-Therapeutics-Inc-stock-gains-62-percent-a-Trade-Record-by-priceSeries-2018030120180327.html

ECYT Endocyte, Inc. gains 152% Mar 27, 2018

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trial to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of advanced solid tumors; and EC1169, a tubulysin therapeutic that is in Phase I dose escalation trial to treat advanced metastatic castration-resistant prostate cancer. The company's products in pre-clinical development include EC2629, a folate receptor-targeted SMDC for use in treating cancer; EC2319 for the treatment of inflammatory diseases; EC0371 for treating polycystic kidney disease; and SMDC bi-specific adaptor chimeric antigen receptor T-cell for the treatment of immunotherapy in cancer. Endocyte, Inc. has a collaboration agreement with Purdue Research Foundation; Master License Agreement with Purdue Research Foundation; Merck Sharp & Dohme Research GmbH; and Nihon Medi-Physic Co., LTD. The company was founded in 1995 and is headquartered in West Lafayette, Indiana. http://www.priceseries.com/trade/ECYT-Endocyte-Inc-stock-gains-152-percent-a-Trade-Record-by-priceSeries-2018022220180327.html

CERS Cerus Corporation gains 23% Mar 27, 2018

Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication; and targets and inactivates blood-borne pathogens, such as viruses, bacteria, and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products. The company's INTERCEPT Blood Systems for platelets and plasma are designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; and INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion. It markets platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was founded in 1991 and is headquartered in Concord, California. http://www.priceseries.com/trade/CERS-Cerus-Corporation-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2018022820180327.html

CCXI ChemoCentryx, Inc. gains 42% Mar 27, 2018

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, develops medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. Its lead drug candidate is Avacopan (CCX168), an orally-administered small molecule that is a selective inhibitor of the complement C5a receptor (C5Ar), which is in Phase III development for the treatment of anti-neutrophil cytoplasmic auto-antibody-associated vasculitis (AAV). The company also engages in developing CCX140, an inhibitor of the chemokine receptor known as CCR2 for patients with focal segmental glomerulosclerosis (FSGS), a debilitating kidney disease; Vercirnon for the treatment of patients with moderate-to-severe Crohn's diseases; CCX872, a selective inhibitor of the human CCR2 that has completed Phase I clinical trial for the treatment of pancreatic cancer; CCX507, which has completed Phase I clinical trial for the treatment of inflammatory bowel diseases; and Th17 cells for the treatment of psoriasis, rheumatoid arthritis, asthma, and multiple sclerosis. It has a partnership with Vifor (International) Ltd. for the geographic commercial rights of Avacopan in Europe and other international markets. ChemoCentryx, Inc. was founded in 1997 and is headquartered in Mountain View, California. http://www.priceseries.com/trade/CCXI-ChemoCentryx-Inc-stock-gains-42-percent-a-Trade-Record-by-priceSeries-2018030120180327.html

ATHX Athersys, Inc. gains 19% Mar 27, 2018

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which has completed Phase 2 study for treating patients suffering from moderate and severe ischemic stroke; that is in Phase 2 clinical study for treating patients with acute myocardial infarction; and, which is in Phase 1/2 clinical study for treating patients with acute respiratory distress syndrome, as well as completed Phase 1 clinical study for patients suffering from leukemia or various other blood-borne cancers. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients; and 5HT2c agonists for the treatment of obesity and other conditions. The company has license and collaboration agreements with Healios K.K. and Chugai Pharmaceuticals Co., Ltd. to develop and commercialize MultiStem cell therapy for ischemic stroke; RTI Surgical, Inc. to develop and commercialize biologic implants for orthopedic applications in the bone graft substitutes market; University of Minnesota to develop MultiStem cell therapy platform; and Bristol-Myers Squibb Company to provide cell lines expressing well validated drug targets for compound screening and development. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio. http://www.priceseries.com/trade/ATHX-Athersys-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2018030920180327.html

SKYS Sky Solar Holdings, Ltd. gains 24% Mar 26, 2018

Sky Solar Holdings, Ltd., an independent power producer, develops, owns, and operates solar parks worldwide. It develops projects; and generates and sells electricity in the downstream solar market. The company also sells solar energy systems, including pipeline and related engineering, construction, and procurement services, as well as is involved in building and transferring solar parks. In addition, it provides operating and maintenance services for solar parks; and sells solar modules. As of December 31, 2015, the company developed 273 solar parks with an aggregate capacity of 252.8 megawatts in Greece, Japan, Bulgaria, the Czech Republic, Spain, Canada, the United States, Germany and Uruguay; and owned and operated 128.6 MW of solar parks. It also had 28.2 megawatts of solar parks under construction, 238.2 megawatts of shovel-ready projects, and 1.0 gigawatt of solar parks in pipeline. Sky Solar Holdings, Ltd. was founded in 2009 and is headquartered in Central, Hong Kong. Sky Solar Holdings, Ltd. is a subsidiary of Sky Power Group Ltd. http://www.priceseries.com/trade/SKYS-Sky-Solar-Holdings-Ltd-stock-gains-24-percent-a-Trade-Record-by-priceSeries-2018022720180326.html

HSII Heidrick & Struggles International, Inc. gains 19% Mar 26, 2018

Heidrick & Struggles International, Inc., together with its subsidiaries, provides executive search, culture shaping, and leadership consulting services on a retained basis to businesses and business leaders in the Americas, Europe, the Asia Pacific, and internationally. The company enables its clients to build leadership teams by facilitating the recruitment, management, and deployment of senior executives. Its leadership consulting services and culture shaping services include leadership assessment; leadership, team, and board development; succession planning; talent strategy; people performance; inter-team collaboration; and organizational transformation. The company also specializes in advising organizations and institutions on strategic planning and decision making. It serves Fortune 1000 companies; middle market and emerging growth companies; governmental, higher education, and not-for-profit organizations; and other private and public entities. Heidrick & Struggles International, Inc. was founded in 1953 and is headquartered in Chicago, Illinois. http://www.priceseries.com/trade/HSII-Heidrick-&-Struggles-International-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2018022720180326.html

DXR Daxor Corporation gains 158% Mar 26, 2018

Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York. http://www.priceseries.com/trade/DXR-Daxor-Corporation-stock-gains-158-percent-a-Trade-Record-by-priceSeries-2018030720180326.html

DRRX Durect Corporation gains 74% Mar 26, 2018

DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and drug delivery programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers for use as raw materials for pharmaceutical and medical devices under the LACTEL brand. Its product pipeline consists of multiple investigational drug candidates in clinical development, such as DUR-928, an endogenous, orally bioavailable small molecule that is in Phase 1 development stage to play a regulatory role in lipid homeostasis, inflammation, and cell survival. The company's advanced oral, injectable, and transdermal delivery technologies are designed to enable new indications and enhanced attributes for small-molecule and biologic drugs, including POSIMIR, an investigational analgesic product intended to deliver bupivacaine to provide up to 3 days of pain relief after surgery; and REMOXY ER, an investigational extended release pain relief drug. DURECT Corporation markets and sells its ALZET and LACTEL product lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has collaboration agreements with Santen Pharmaceutical Co., Ltd.; Impax Laboratories, Inc.; Zogenix, Inc.; and Pain Therapeutics, Inc. DURECT Corporation was founded in 1998 and is headquartered in Cupertino, California. http://www.priceseries.com/trade/DRRX-Durect-Corporation-stock-gains-74-percent-a-Trade-Record-by-priceSeries-2018022120180326.html

AKCA Akcea Therapeutics, Inc. gains 43% Mar 26, 2018

N/A http://www.priceseries.com/trade/AKCA-Akcea-Therapeutics-Inc-stock-gains-43-percent-a-Trade-Record-by-priceSeries-2018031420180326.html

AGLE Aeglea Biotherapeutics, Inc. gains 49% Mar 26, 2018

Aeglea Biotherapeutics, Inc., a biopharmaceutical company, engages in developing engineered human enzymes for the treatment of inborn errors of metabolism and cancer. It develops AERase/AEB1102, an amino acid for the degradation of arginine in the circulation, as well as for the treatment of hyperargininemia and cancer; and AECase/AEB3103, an engineered and PEGylated human cysteine/cystine degrading enzyme that increases oxidative stress through glutathione depletion for treatment of hematologic and solid malignancies. The company also engages in developing AEMase/AEB2109, an engineered human enzyme that degrades methionine for the treatment of solid tumors; and AEB4104, an engineered human enzyme that degrades homocysteine in the circulation for the treatment of inborn error of metabolism homocystinuria. It has a strategic partnership with KBI Biopharma. Aeglea Biotherapeutics, Inc. was formerly known as Aeglea BioTherapeutics Holdings, LLC. The company was founded in 2013 and is based in Austin, Texas. http://www.priceseries.com/trade/AGLE-Aeglea-Biotherapeutics-Inc-stock-gains-49-percent-a-Trade-Record-by-priceSeries-2018022720180326.html

ZSAN Zosano Pharma Corporation gains 73% Mar 23, 2018

Zosano Pharma Corporation, a clinical stage pharmaceutical company, develops a proprietary intracutaneous delivery system to administer drugs through the skin for rapid symptom relief to patients. Its lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. http://www.priceseries.com/trade/ZSAN-Zosano-Pharma-Corporation-stock-gains-73-percent-a-Trade-Record-by-priceSeries-2018030620180323.html

WIX Wix.com Ltd. gains 30% Mar 23, 2018

Wix.com Ltd. develops and markets an Internet service that allows users to create Web content in Latin America, Europe, North America, Asia, and internationally. It offers Web development, design, and management solutions and apps through an online platform that enables its user base of businesses, organizations, professionals, and individuals to create a digital presence. The company's principal product is the Wix Editor, a drag-and-drop visual development and Website editing environment. Its applications and value-added solutions comprise Wix App Market, an online platform that offers its users a range of software apps, which could be integrated as add-ons into its users' Websites. In addition, the company provides WixShoutOut, which enables users to create and send customized email campaigns, such as newsletters, updates, and promotions directly from their Wix accounts. Further, it offers WixStores that allows its users to create, design, and manage an online store through which they may sell their products online and process payments using an integrated shopping cart app; Wix Bookings, an end-to-end online appointment booking solution; WixHotels, a Website for hotels, B&Bs, and vacation rentals; WixMusic, an advanced music player solution; and Wix Restaurants that provides various solutions for restauranteurs, including Wix Restaurants menus, orders, and reservations. Additionally, the company provides Wix Photography, a solution for photographers looking to create their portfolio and manage their business online; Wix Video that allows its customers to showcase, promote, and sell videos on their Wix Website; and customer support and services. As of December 31, 2016, it had approximately 97.3 million registered users and 2,465,160 premium subscriptions. The company was formerly known as Wixpress Ltd. Wix.com Ltd. was founded in 2006 and is headquartered in Tel Aviv, Israel. http://www.priceseries.com/trade/WIX-Wixcom-Ltd-stock-gains-30-percent-a-Trade-Record-by-priceSeries-2018021220180323.html

TWLO Twilio Inc gains 56% Mar 23, 2018

Twilio Inc. provides cloud communications platform that enables developers to build, scale, and operate communications within software applications through the cloud as a pay-as-you-go service in the United States and internationally. It offers programmable communications cloud software that enables developers to embed voice, messaging, video, and authentication capabilities into their applications through application programming interfaces. The company also provides use case products, such as a two-factor authentication solution. Twilio Inc. was founded in 2008 and is headquartered San Francisco, California. http://www.priceseries.com/trade/TWLO-Twilio-Inc-stock-gains-56-percent-a-Trade-Record-by-priceSeries-2018021220180323.html

SQ Square, Inc. gains 16% Mar 23, 2018

Mobile payment service provider for small businesses. http://www.priceseries.com/trade/SQ-Square-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2018030220180323.html

SPRO Spero Therapeutics, Inc. gains 17% Mar 23, 2018

SmartPros Ltd. provides learning and educational solutions for accounting/finance, legal, engineering, securities, and insurance markets. It offers accounting and finance libraries; executive enterprise institute, a series of live seminars in the corporate and public accountant marketplace; SmartPros Advantage, a skills-based learning library; and Financial Management Network, a library of programs dealing with current topics. The company also provides CPA Report (CPAR), a library of programs covering topics in public accounting; and CPAR Government and Not-for-Profit, a library of designed for accounting professionals. Its engineering library includes FE Exam Review, a preparatory course for the basic entry-level licensing exam; PE Civil Exam review, a course for civil engineers; and a series of self-study PE Civil Exam preparation courses that cover the civil, mechanical, electrical, and chemical disciplines. In addition, the company offers engineering and management courses for professional development hours; project management for engineers; construction project management; and supply chain and certified in production and inventory management certification courses. Further, it provides online educational courses covering Occupational Safety and Health Act regulatory compliance, hazardous material handling, and environmental and safety topics. Additionally, the company develops corporate governance, compliance, and ethics programs for employees and managers; and provides continuing legal education courses. The company also offers online courses for the banking, insurance, and securities industries; and information technology courses programs. Its courses are offered in text and video-interactive formats, live education, and Webinars. The company was formerly known as KeepSmart.com, Inc. and changed its name to SmartPros Ltd. in June 2001. SmartPros Ltd. was founded in 1981 and is headquartered in Hawthorne, New York. http://www.priceseries.com/trade/SPRO-Spero-Therapeutics-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2018030820180323.html

SEDG SolarEdge Technologies, Inc. gains 58% Mar 23, 2018

SolarEdge Technologies, Inc., together with its subsidiaries, designs, develops, and sells direct current (DC) optimized inverter systems for solar photovoltaic (PV) installations in Israel, Europe, the United States, and internationally. The company's DC optimized inverter systems include power optimizers, inverters, and cloud-based monitoring software. Its products are used in a range of solar market segments, including residential, commercial, and small utility-scale solar installations. The company sells its products directly to solar installers, as well as engineering, procurement, and construction firms; and indirectly to solar installers through distributors and electrical equipment wholesalers, as well as PV module manufacturers. SolarEdge Technologies, Inc. was founded in 2006 and is headquartered in Herziliya Pituach, Israel. http://www.priceseries.com/trade/SEDG-SolarEdge-Technologies-Inc-stock-gains-58-percent-a-Trade-Record-by-priceSeries-2018021220180323.html

SBPH Spring Bank Pharmaceuticals Inc gains 23% Mar 23, 2018

Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its SMNH compounds are small segments of nucleic acids that are design to target and modulate the activity of specific proteins implicated in various disease states. The company's lead product candidate is SB 9200, which completed a Phase 1 clinical trial for the treatment of chronic hepatitis B virus and respiratory syncytial virus. It also develops SMNH product candidate, SB 11285, an immunotherapeutic agent for the treatment of selected cancers; and SB 9400, SB 9941 and SB 9946 preclinical product candidates for viral diseases. The company has an agreement with Arrowhead Pharmaceuticals, Inc. to collaborate on the study of the combined use of SB 9200 and small interfering ribonucleic acid product pipeline for the treatment of chronic hepatitis B virus (HBV); and Arbutus Biopharma Corporation to collaborate on the preclinical study of the combined use of SB 9200 and AB-423, a capsid assembly inhibitor for the treatment of chronic HBV. The company was formerly known as Spring Bank Technologies, Inc. and changed its name to Spring Bank Pharmaceuticals, Inc. in May 2008. Spring Bank Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Hopkinton, Massachusetts. http://www.priceseries.com/trade/SBPH-Spring-Bank-Pharmaceuticals-Inc-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2018022320180323.html

RRD R.R. Donnelley & Sons Company gains 18% Mar 23, 2018

R.R. Donnelley & Sons Company enables organizations to communicate by creating, managing, delivering, and optimizing their multichannel marketing and business communications. It operates through Variable Print, Strategic Services, and International segments. The company's primary product and service offerings include magazines, catalogs, retail inserts, books, directories, direct mail, packaging, forms, labels, manuals, statement printing, commercial and digital print, logistics services and digital and creative solutions. It also offers outsourcing capabilities, including product configuration, customized kitting, and order fulfillment for technology, medical device, and other companies. The company has operations in Europe, Asia, and North America. R.R. Donnelley & Sons Company was founded in 1864 and is based in Chicago, Illinois. http://www.priceseries.com/trade/RRD-RR-Donnelley-&-Sons-Company-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2018030220180323.html

RKDA Arcadia Biosciences, Inc. gains 502% Mar 23, 2018

Arcadia Biosciences, Inc., an agricultural biotechnology trait company, develops traits that enhance food, feed, and fiber crops worldwide. The company offers a suite of agricultural yield traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, herbicide tolerance, and heat tolerance traits, as well as yield and agronomic trait stacks primarily for food crops, such as corn, rice, wheat, and soybean. It also provides agricultural product quality traits comprising gamma linolenic acid safflower oil to manufacturers of nutritional supplements, medical foods, and other products under the SONOVA brand; and arachidonic acid safflower oil that is used as an ingredient in infant nutrition products. In addition, the company has various programs under development comprising resistant starch and wheat whole grain flour quality grains programs, as well as post harvest quality program for tomatoes. Its traits are used to enhance crop yields by enabling plants to manage environmental and nutrient stresses, as well as enhance the quality and value of agricultural products. Arcadia Biosciences, Inc. primarily has collaborations with Maharashtra Hybrid Seeds Company Ltd.; Vilmorin & Cie; Bioceres S.A.; and Dow AgroSciences for the development and commercialization of its traits in various crops and consumer products. The company was founded in 2002 and is headquartered in Davis, California. http://www.priceseries.com/trade/RKDA-Arcadia-Biosciences-Inc-stock-gains-502-percent-a-Trade-Record-by-priceSeries-2018030220180323.html

PGNX Progenics Pharmaceuticals Inc. gains 16% Mar 23, 2018

Progenics Pharmaceuticals, Inc. develops medicines and other technologies to target and treat cancer in the United States and internationally. The company's primary clinical-stage product candidates include Azedra, a radiotherapeutic product candidate, which is in Phase IIb clinical trial under special protocol assessment for the treatment of malignant and/or recurrent pheochromocytoma and paraganglioma; 1404, a technetium-99m labeled small molecule that has completed Phase II testing, as well as acts as an imaging agent to diagnose and detect prostate cancer, as well as soft tissue and bone metastases; and PyL, a fluorinated prostate specific membrane antigen (PSMA)-targeted positron emission topography (PET) imaging agent for prostate cancer. Its clinical-stage product candidates also comprise 1095, a PSMA-targeted Iodine-131 labeled small radiopharmaceutical molecule for the treatment of metastatic castration-resistant prostate cancer; PSMA TTC, a thorium-227 labeled PSMA-targeted antibody therapeutic that is in pre-clinical stage for treatment of metastatic prostate cancer; and EXINI bone BSI range of prostate cancer bone scan indexing products. The company also offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness adult patients receiving palliative care when laxative therapy has not been sufficient, as well as for treatment of OIC in patients with non-cancer pain; and Relistor-oral tablets for the treatment of OIC. The company has license agreement with Salix Pharmaceuticals, Inc. for the development and commercialization of Relistor worldwide; and with Amgen Fremont, Inc. to use its XenoMouse technology for generating human antibodies to PSMA, as well as has collaboration agreement with Seattle Genetics, Inc. Progenics Pharmaceuticals, Inc. was founded in 1986 and is based in New York, New York. http://www.priceseries.com/trade/PGNX-Progenics-Pharmaceuticals-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2018022320180323.html

PEN Penumbra, Inc. gains 17% Mar 23, 2018

Markets devices for neuro and peripheral vascular conditions and diseases. http://www.priceseries.com/trade/PEN-Penumbra-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2018022320180323.html

NVEE NV5 Global, Inc. gains 19% Mar 23, 2018

NV5 Global, Inc. provides professional and technical engineering, and consulting solutions to public and private sector clients in the infrastructure, energy, construction, real estate, and environmental markets in the United States and internationally. It operates through two segments, Infrastructure and Buildings, Energy & Science. The company offers infrastructure, engineering, and support services, including site selection, design, water resources, transportation, structural engineering, land development, surveying, power delivery, building code compliance, and other service areas; and construction quality assurance services, such as construction materials testing and engineering, geotechnical engineering and consulting, and forensic consulting. It also provides civil program management services comprising governmental outsourcing and consulting services; and technical outsourcing services, as well as building program management services. In addition, the company offers energy services, including inspection, and assistance in permitting; and traditional engineering services, such as energy and underground transmission and distribution, substation engineering, and power generation facility design services and surveying. Further, it provides environmental services comprising investigating and analyzing environmental conditions, and recommending corrective measures and procedures; occupational health and safety services; hydrogeological modeling and environmental programs; water resource planning, monitoring, and environmental management of wastewater facilities; solid waste landfill investigations; permitting and compliance; storm water pollution; environmental impact statement support; agricultural waste management and permitting; and wetland evaluations. The company was formerly known as NV5 Holdings, Inc. and changed its name to NV5 Global, Inc. in December 2015. NV5 Global, Inc. was founded in 1949 and is headquartered in Hollywood, Florida. http://www.priceseries.com/trade/NVEE-NV5-Global-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2018030620180323.html

NTNX Nutanix Inc gains 54% Mar 23, 2018

Nutanix Inc provides next-generation enterprise cloud platform that converges traditional silos of server, virtualization and storage into one integrated solution and can also connect to public cloud services. http://www.priceseries.com/trade/NTNX-Nutanix-Inc-stock-gains-54-percent-a-Trade-Record-by-priceSeries-2018021220180323.html

MU Micron Technology, Inc. gains 17% Mar 23, 2018

Micron Technology, Inc. provides semiconductor systems worldwide. The company operates through four segments: Compute and Networking Business Unit, Storage Business Unit, Mobile Business Unit, and Embedded Business Unit. It offers DDR3 and DDR4 DRAM products for computers, servers, networking devices, communications equipment, consumer electronics, automotive, and industrial applications; mobile low-power DRAM products for smartphones, tablets, automotive, laptop computers, and other mobile consumer device applications; DDR2 and DDR DRAM, GDDR5 and GDDR5X DRAM, SDRAM, and RLDRAM products for networking devices, servers, consumer electronics, communications equipment, computer peripherals, automotive and industrial applications, and computer memory upgrades; and hybrid memory cube semiconductor memory devices for use in networking and computing applications. The company also provides NAND Flash products, which are electrically re-writeable, non-volatile semiconductor memory devices; client solid-state drives (SSDs) for notebooks, desktops, workstations, and other consumer applications; enterprise SSDs for server and storage applications; managed multi-chip package products; digital media products, including flash memory cards and JumpDrive products under the Lexar brand name. In addition, it manufactures products that are sold under other brand names; and resells flash memory products that are purchased from other NAND Flash suppliers. Further, the company provides 3D XPoint memory products; and NOR Flash, which are electrically re-writeable and semiconductor memory devices for automotive, industrial, connected home, and consumer applications. It markets its products to original equipment manufacturers and retailers through its internal sales force, independent sales representatives, and distributors; and through a Web-based customer direct sales channel, and channel and distribution partners. The company was founded in 1978 and is headquartered in Boise, Idaho. http://www.priceseries.com/trade/MU-Micron-Technology-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2018030220180323.html

MGEN Miragen Therapeutics Inc. gains 23% Mar 23, 2018

Signal Genetics, Inc., a commercial stage molecular genetic diagnostic company, focuses on providing diagnostic services that assist physicians in decision making for the care of patients suffering from cancer. The company primarily offers Myeloma Prognostic Risk Signature (MyPRS) test, a microarray-based gene expression profiling assay that tests for the presence of specific groups of genes that could predict low or high level risk of early relapse in patients suffering from multiple myeloma. Signal Genetics, Inc. was founded in 2010 and is headquartered in Carlsbad, California. http://www.priceseries.com/trade/MGEN-Miragen-Therapeutics-Inc-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2018030220180323.html

KFY Korn/Ferry International gains 15% Mar 23, 2018

Korn/Ferry International, together with its subsidiaries, provides talent management solutions worldwide. It operates through three segments: Executive Recruitment, Hay Group, and Futurestep. The company provides executive recruitment services that are used to fill executive-level positions, such as board directors, CEOs, chief financial officers, chief operating officers, chief information officers, and other senior executive officers for clients in the consumer, financial services, industrial, life sciences/healthcare provider, technology, and educational/not-for-profit industries. It also offers talent strategy, succession management, and leadership development solutions to assist clients with their ongoing assessment, organizational design, and leadership development efforts. In addition, the company provides various talent acquisition solutions, including recruitment process outsourcing, project recruitment, professional search, talent consulting and talent communications, and individual professional search and consulting services. It serves public and private companies, and middle market and emerging growth companies, as well as government and non-profit organizations. The company was founded in 1969 and is based in Los Angeles, California. http://www.priceseries.com/trade/KFY-KornFerry-International-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2018030520180323.html

GTT GTT Communications, Inc. gains 23% Mar 23, 2018

GTT Communications, Inc. provides cloud networking services to multinational enterprises, carriers, and government customers worldwide. It offers private, public, and hybrid cloud network solutions; high bandwidth-Internet connectivity and IP transit, as well as broadband and wireless access services; managed equipment, security, and remote access services; and voice and unified communications services consisting of SIP trunking and enterprise PBX services. The company's IP network consists of approximately 250 points of presence. GTT Communications, Inc. markets its products and services through a network of direct sales force and indirect sales channels. The company was formerly known as Global Telecom & Technology, Inc. and changed its name to GTT Communications, Inc. in January 2014. GTT Communications, Inc. was incorporated in 2005 and is headquartered in McLean, Virginia. http://www.priceseries.com/trade/GTT-GTT-Communications-Inc-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2018022320180323.html

FBIO Fortress Biotech, Inc. gains 35% Mar 23, 2018

Coronado Biosciences, Inc., a biopharmaceutical company, develops novel immunotherapy agents for the treatment of autoimmune diseases and cancer. Its principal pharmaceutical product candidates in clinical development include Trichuris suis ova or... http://www.priceseries.com/trade/FBIO-Fortress-Biotech-Inc-stock-gains-35-percent-a-Trade-Record-by-priceSeries-2018022120180323.html

ETSY Etsy, Inc. gains 40% Mar 23, 2018

Etsy, Inc. operates as a commerce platform to make, sell, and buy goods online and offline worldwide. Its platform includes its markets, services, and technology, which enables to engage a community of sellers and buyers. The company offers approximately 45 million items across approximately 50 retail categories to buyers. It also provides various seller services, including direct checkouts, promoted listings, and shipping labels, as well as Pattern by Etsy to create custom Websites; and seller tool and education resources to start, manage, and scale businesses to entrepreneurs primarily through Etsy.com. In addition, the company operates A Little Market, a handmade and supplies market for sellers and buyers. Etsy, Inc. was founded in 2005 and is headquartered in Brooklyn, New York. http://www.priceseries.com/trade/ETSY-Etsy-Inc-stock-gains-40-percent-a-Trade-Record-by-priceSeries-2018021320180323.html

APTO Aptose Biosciences, Inc. gains 24% Mar 23, 2018

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, a small molecule that induces the transcription of the Kruppel-like factor 4 Gene in in vitro studies and in in vivo pharmacodynamic studies of human xenograft tumors in mice. The company's APTO-253 clinical program has completed Phase-I clinical trials for the treatment of various solid tumors; and Phase-Ib clinical trials for relapsed/refractory hematologic malignancies. It also develops APTO-500 program that focuses on discovering and developing small molecule inhibitors of maternal embryonic leucine zipper kinase; and is in a pre-clinical stage for oncology. It has a license agreement with Genentech Inc. to develop and sub-license a specified polypeptide; and collaboration agreement with Eli Lilly and Company to investigate a proprietary series of the company's compounds for veterinary medicine. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Mississauga, Canada. http://www.priceseries.com/trade/APTO-Aptose-Biosciences-Inc-stock-gains-24-percent-a-Trade-Record-by-priceSeries-2018030220180323.html

ADRO Aduro Biotech, Inc. gains 36% Mar 23, 2018

Aduro BioTech, Inc., an immunotherapy company, focuses on the discovery, development, and commercialization that transform the treatment of challenging diseases. It is developing CRS-207, which has completed Phase Ib clinical trials for the treatment of unresectable malignant pleural mesothelioma; that has completed Phase II clinical trials for the treatment of pancreatic cancer; and that is in Phase I/II clinical trials for the treatment of ovarian cancer. The company is also developing ADU-214 that is in Phase I clinical trials for the treatment of lung cancer; ADU-741, which is in Phase I clinical trials for the treatment of prostate cancer; and a product candidate for the treatment of patients with cancers of the gastrointestinal tract. In addition, it is developing STING Pathway Activator product candidates that are synthetic small molecule immune modulators, which target and activate Stimulator of Interferon Genes receptor under collaboration with Novartis Pharmaceuticals Corporation; and product candidates that address other therapeutic areas, such as autoimmune and infectious diseases. Further, the company's products pipeline comprises BION-1301, a B-select mAb novel therapy for multiple myeloma; and antibody product candidates, including APRIL for the treatment of multiple myeloma, as well as oncology therapies, such as CD27, PD-1, and CTLA-4. Aduro BioTech, Inc. has a collaboration agreement with Janssen Biotech, Inc. to develop drugs for the treatment of prostate and lung cancers; and development and commercialization agreement with Genmab to evaluate five bispecific antibody product candidates targeting immune checkpoints. The company was formerly known as Oncologic, Inc. and changed its name to Aduro BioTech, Inc. in June 2008. Aduro BioTech, Inc. was founded in 2000 and is headquartered in Berkeley, California. http://www.priceseries.com/trade/ADRO-Aduro-Biotech-Inc-stock-gains-36-percent-a-Trade-Record-by-priceSeries-2018030220180323.html

AAC AAC Holdings, Inc. gains 42% Mar 23, 2018

AAC Holdings, Inc. provides inpatient substance abuse treatment services for individuals with drug and alcohol addiction in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention services. As of December 31, 2016, the company operated 12 residential substance abuse treatment facilities, 18 standalone outpatient centers, and 202 sober living beds. It also offers Internet marketing services to families and individuals, who are struggling with addiction and seeking treatment options through online directories of treatment providers, treatment provider reviews, forums, and professional communities; and online marketing solutions to other treatment providers, such as facility profiles, audience targeting, lead generation, and tools for digital reputation management. In addition, it performs drug testing and diagnostic laboratory services; and provides physician services to its clients. AAC Holdings, Inc. was incorporated in 2014 and is headquartered in Brentwood, Tennessee. http://www.priceseries.com/trade/AAC-AAC-Holdings-Inc-stock-gains-42-percent-a-Trade-Record-by-priceSeries-2018022120180323.html

ZG Zillow Group, Inc. gains 17% Mar 22, 2018

Zillow Group, Inc. operates real estate and home-related information marketplaces on mobile and the Web in the United States. The company offers a portfolio of brands and products to enable people find information about homes and connect with local professionals. Its brands focus on various stages of the home lifecycle, including renting, buying, selling, and financing. The company's portfolio of consumer brands comprises real estate and rental marketplaces, such as Zillow, Trulia, StreetEasy, HotPads, and Naked Apartments. It also owns and operates various brands comprising Mortech, dotloop, Bridge Interactive, and Retsly, as well as provides advertising services to real estate agents, and rental and mortgage professionals. The company was incorporated in 2004 and is headquartered in Seattle, Washington. http://www.priceseries.com/trade/ZG-Zillow-Group-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2018022820180322.html

Z Zillow Group, Inc. gains 17% Mar 22, 2018

Zillow Group, Inc. operates real estate and home-related information marketplaces on mobile and the Web in the United States. The company offers a portfolio of brands and products to enable people find information about homes and connect with local professionals. Its brands focus on various stages of the home lifecycle, including renting, buying, selling, and financing. The company's portfolio of consumer brands comprises real estate and rental marketplaces, such as Zillow, Trulia, StreetEasy, HotPads, and Naked Apartments. It also owns and operates various brands comprising Mortech, dotloop, Bridge Interactive, and Retsly, as well as provides advertising services to real estate agents, and rental and mortgage professionals. The company was incorporated in 2004 and is headquartered in Seattle, Washington. http://www.priceseries.com/trade/Z-Zillow-Group-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2018022820180322.html

WDC Western Digital Corporation gains 20% Mar 22, 2018

Western Digital Corporation, together with its subsidiaries, develops, manufactures, and sells data storage devices and solutions worldwide. It offers performance hard disk drives (HDDs) that are used in enterprise servers, data analysis, and other enterprise applications; capacity HDDs and drive configurations for use in data storage systems and tiered storage models, as well as for use in storage of data for years; and enterprise solid state drives (SSDs), including NAND-flash SSDs and software solutions that are designed to enhance the performance in various enterprise workload environments. The company also provides InfiniFlash System, a system solution that offers petabyte scalable capacity with performance metrics; higher value data storage platforms and systems; datacenter software and systems; and HDDs and SSDs for desktop PCs, notebook PCs, gaming consoles, set top boxes, security surveillance systems, and other computing devices. In addition, it offers embedded NAND-flash storage products, including custom embedded solutions; and iNAND embedded flash products, such as multi-chip package solutions that combine NAND and mobile dynamic random-access memory in an integrated package for mobile phones, tablets, notebook PCs, and other portable and wearable devices, as well as in automotive and connected home applications, and NAND-flash wafers. Further, it provides HDDs embedded into WD- and HGST-branded external storage products; and NAND-flash products, which include cards, universal serial bus flash drives, and wireless drives. Additionally, the company licenses its technologies. The company sells its products under the HGST, SanDisk, and WD brands to original equipment manufacturers (OEMs), distributors, resellers, cloud infrastructure players, and retailers. It serves storage subsystem suppliers, OEMs, Internet and social media infrastructure players, and PC and Mac OEMs. The company was founded in 1970 and is headquartered in Irvine, California. http://www.priceseries.com/trade/WDC-Western-Digital-Corporation-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2018021520180322.html

VRTV Veritiv Corporation gains 35% Mar 22, 2018

Veritiv Corporation operates as a business-to-business distributor of print, publishing, packaging, and facility solutions in the United States, Mexico, and Canada. It operates through four segments: Print, Publishing & Print Management (Publishing), Packaging, and Facility Solutions. The Print segment sells and distributes commercial printing, writing, copying, digital, wide format, and specialty paper products; and graphics consumables and equipment. This segment also provides customized paper conversion services of commercial printing paper for distribution to document centers and form printers. The Publishing segment sells and distributes coated and uncoated commercial printing papers to publishers, retailers, converters, printers, and specialty businesses for use in magazines, catalogs, books, directories, gaming, couponing, retail inserts, and direct mail. This segment also provides print management, procurement, and supply chain management solutions. The Packaging segment offers standard and custom packaging solutions. The Facility Solutions segment sources and sells cleaning, break-room, and other supplies, such as towels, tissues, wipers and dispensers, can liners, commercial cleaning chemicals, soaps and sanitizers, sanitary maintenance supplies and equipment, safety and hazard supplies, and shampoos and amenities. The company also provides logistics and supply chain management solutions. It offers its products under the Endurance, nordic+, Econosource, Comet, Starbrite Opaque Select, TUFflex, Reliable, and Spring Grove brands, as well as other brands to printers, publishers, data centers, manufacturers, higher education institutions, healthcare facilities, sporting and performance arenas, retail stores, government agencies, property managers, and building service contractors. As of March 14, 2017, the company operated 170 distribution centers. Veritiv Corporation was incorporated in 2013 and is headquartered in Atlanta, Georgia. http://www.priceseries.com/trade/VRTV-Veritiv-Corporation-stock-gains-35-percent-a-Trade-Record-by-priceSeries-2018030120180322.html

VEEV Veeva Systems Inc. gains 29% Mar 22, 2018

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, which allow pharmaceutical and biotechnology companies to target and support sales and marketing to physicians, other healthcare professionals, and healthcare organizations through various touch points, including in-person, email, and online; and Veeva Vault, a cloud-based enterprise content management platform and suite of applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, and quality. It also provides Veeva Network master data management solutions for the management of customer master and product master data. In addition, the company offers data solutions and services comprising Veeva OpenData, Veeva OpenData data services, Veeva OpenData email, and Veeva key opinion leader data and services, as well as territory allocation and alignment applications. Further, it provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was founded in 2007 and is headquartered in Pleasanton, California. http://www.priceseries.com/trade/VEEV-Veeva-Systems-Inc-stock-gains-29-percent-a-Trade-Record-by-priceSeries-2018021420180322.html